We are live on ! Find out more
SC

Stempoint Capital Portfolio holdings

AUM $522M
1-Year Est. Return 281.95%
This Fund
S&P 500
This Quarter Est. Return
+25.39%
1 Year Est. Return
+281.95%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$375M
AUM Growth
Cap. Flow
+$315M
Cap. Flow %
83.93%
Top 10 Hldgs %
39.49%
Holding
67
New
67
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
ROIV icon
Roivant Sciences
ROIV
+$21.1M
2
SNDX icon
Syndax Pharmaceuticals
SNDX
+$16.8M
3
ACLX
Arcellx
ACLX
+$14.1M
4
IMVT icon
Immunovant
IMVT
+$11.8M
5
MRUS
Merus
MRUS
+$11.7M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 91.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARWR icon
51
Arrowhead Research
ARWR
$12.1B
$1.81M 0.48%
+59,038
New +$1.57M
AMAM
52
DELISTED
Ambrx Biopharma Inc
AMAM
$1.8M 0.48%
+126,101
New +$1.43M
RAPT
53
DELISTED
RAPT Therapeutics
RAPT
$1.45M 0.39%
+7,306
New +$904K
OCUL icon
54
Ocular Therapeutix
OCUL
$1.86B
$1.25M 0.33%
+279,648
New +$827K
AMLX icon
55
Amylyx Pharmaceuticals
AMLX
$2.05B
$1.23M 0.33%
+83,381
New +$1.28M
SPY icon
56
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$1.19M 0.32%
+6,500
New +$2.9M
STTK icon
57
Shattuck Labs
STTK
$710M
$1.05M 0.28%
+147,752
New +$403K
ANAB icon
58
AnaptysBio
ANAB
$1.6B
$964K 0.26%
+45,000
New +$776K
TARS icon
59
Tarsus Pharmaceuticals
TARS
$2.56B
$628K 0.17%
+30,990
New +$517K
CRGX
60
DELISTED
CARGO Therapeutics
CRGX
$622K 0.17%
+26,875
New +$456K
IWM icon
61
PUT
iShares Russell 2000 ETF
IWM
$80.9B
$574K 0.15%
+1,500
New +$269K
ARKG icon
62
PUT
ARK Genomic Revolution ETF
ARKG
$1.51B
$375K 0.1%
+5,000
New +$136K
IRON icon
63
CALL
Disc Medicine
IRON
$2.83B
$371K 0.1%
+1,000
New +$51.2K
IBB icon
64
PUT
iShares Biotechnology ETF
IBB
$9.31B
$360K 0.1%
+2,000
New +$244K
MLTX icon
65
PUT
MoonLake Immunotherapeutics
MLTX
$1.59B
$335K 0.09%
+500
New +$25.8K
ACLX
66
CALL
DELISTED
Arcellx
ACLX
$283K 0.08%
+623
New +$28.1K
QQQ icon
67
PUT
Invesco QQQ Trust
QQQ
$455B
$232K 0.06%
+600
New +$228K

Similar funds

Stempoint Capital's Q4 2023 Portfolio in Review

Q4 2023 is the first quarter with a 13F filing on record for Stempoint Capital, which disclosed 67 positions worth $375M. Its ten largest holdings account for 39% of the portfolio.

Its largest position is Roivant Sciences: 2,169,116 shares worth $24.4M.

By sector, the portfolio is most concentrated in Healthcare at 92% of assets.

  • Stempoint Capital's largest Q4 2023 buy was Roivant Sciences: 2,169,116 shares worth $24.4M.
  • Stempoint Capital's ten largest holdings make up 39% of its $375M portfolio in Q4 2023.
  • Stempoint Capital disclosed 67 positions in Q4 2023, its first 13F filing on record.

Based on Stempoint Capital's 13F filing for Q4 2023, filed 13 Feb 2024.